Repligen

Founded in 1981 and headquartered in Waltham, Massachusetts, Repligen is a bioprocessing-focused life sciences company. It inspires advances in bioprocessing through high-value products and flexible solutions for biologic drug production. These offerings address critical steps, enhancing efficiency and quality. Repligen's focus on innovation positions it as a key player in biotechnology and pharmaceuticals. Learn about Repligen's global headquarters for detailed location information.

With 24 locations, Repligen generated $763.3M in revenue and employs 1,000-5,000 individuals. Its product portfolio includes bioprocessing consumables, life science tools, and purification technologies like chromatography resins, filtration systems, and affinity ligands. These are critical for biopharmaceutical development and manufacturing, supporting processes from cell culture to downstream purification. Meet Repligen's team to understand the expertise driving these innovations.

Repligen competes with Bio-Techne, Celltrion, and AGC Biologics, among others. The company's commitment to technology leadership and providing reliable, high-quality solutions underscores its mission to accelerate the development and delivery of life-saving biologic drugs. By focusing on critical bioprocessing needs, Repligen continues to be an indispensable partner for biopharmaceutical manufacturers worldwide, driving progress in healthcare.